Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 17,552 | 18,346 | 18,236 | 22,071 | 21,609 |
| Cost of Goods | 9,451 | 8,995 | 8,034 | 19,334 | 9,229 |
| Gross Profit | 8,101 | 9,351 | 10,202 | 2,737 | 12,380 |
| Operating Expenses | 15,660 | 19,505 | 23,474 | 23,770 | 30,007 |
| Operating Income | -7,108 | -9,159 | -13,238 | -20,699 | -17,398 |
| Interest Expense | 31,783 | 4,214 | 3,909 | 3,651 | 4,006 |
| Other Income | 3,190 | 1,662 | 10 | -23 | 17 |
| Pre-tax Income | -35,701 | -11,711 | -17,137 | -24,373 | -21,387 |
| Net Income Continuous | -35,701 | -11,711 | -17,137 | -24,373 | -21,387 |
| Net Income | $-35,701 | $-11,711 | $-17,137 | $-24,373 | $-21,387 |
| EPS Basic Total Ops | -600.00 | -200.00 | -326.00 | -468.00 | -500.00 |
| EPS Basic Continuous Ops | -559.26 | -206.07 | -326.30 | -487.68 | -457.08 |
| EPS Diluted Total Ops | -600.00 | -200.00 | -326.00 | -468.00 | -500.00 |
| EPS Diluted Continuous Ops | -559.26 | -206.07 | -326.30 | -487.68 | -457.08 |
| EPS Diluted Before Non-Recurring Items | -460.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-5,016 | $-5,642 | $-12,701 | $-9,506 | $-15,056 |